BRIDGEWATER, N.J. – Bausch + Lomb announced that BASES, a Nielsen Global Consumer business division, has named LUMIFY (brimonidine tartrate ophthalmic solution 0.025%) redness reliever eye drops to its 2020 U.S. BASES Top 25 Breakthrough Innovations List in the “Superstar” category for its success in driving sales and category growth. The Top 25 Breakthrough Innovations
BRIDGEWATER, N.J. – Bausch + Lomb announced on Monday the U.S. launch of PreserVision AREDS 2 Formula minigel eye vitamins. The new minigels will replace the currently offered PreserVision AREDS 2 Formula soft gels, offering patients an easier-to-swallow option as compared to the original AREDS 2 soft gels. PreserVision AREDS 2 Formula minigel eye vitamins
BRIDGEWATER, N.J. – Bausch + Lomb announced Tuesday the U.S. launch of Ocuvite Eye Performance, an eye vitamin supplement formulated with seven vital nutrients that help strengthen the macula, which helps protect the eye from the stress of sun light and blue light emitted from digital devices. This new offering was created to meet the
NEW YORK — Bausch + Lomb recently celebrated the launch of Lumify, a new eye drop product and brand aimed at reducing eye redness, at the Gallery at the Metropolitan Pavilion in Chelsea. Chris Marschall, vice president of marketing, Consumer Health Care, at Bausch + Lomb, said he is excited about the Lumify launch not
